Wendy Lauren Levine

CIK: 0001881038

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

APYX

Apyx Medical Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

APYX
Apyx Medical Corp
Jun 11, 2026
Award(A)
Stock Option (Option to Buy)
Direct
50K shares-
APYX
Apyx Medical Corp
May 15, 2025
Award(A)
Stock Option (Option to Buy)
Direct
64K shares-
APYX
Apyx Medical Corp
Jan 15, 2025
Award(A)
Stock Option (Option to Buy)
Direct
50K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	APYX Apyx Medical Corp	Award(A) Stock Option (Option to Buy)	50,000	-	-	Direct
May 15, 2025	APYX Apyx Medical Corp	Award(A) Stock Option (Option to Buy)	64,000	-	-	Direct
Jan 15, 2025	APYX Apyx Medical Corp	Award(A) Stock Option (Option to Buy)	50,000	-	-	Direct

1-3 of 3 transactions

About Levine Wendy Lauren

Levine Wendy Lauren (SEC CIK 0001881038) files insider reports with the SEC as Director of Apyx Medical Corp (APYX).

Signal8 holds 3 ownership filings by Levine Wendy Lauren, all Form 4s, filed between Jan 17, 2025 and Jun 15, 2026. Those filings report 3 transactions, from Jan 15, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Levine Wendy Lauren's filings is in CLEARWATER, FL.

Recent filings by Levine Wendy Lauren

Jun 11, 2026: Grant or award of APYX derivative securities (Form 4, code A).
May 15, 2025: Grant or award of APYX derivative securities (Form 4, code A).
Jan 15, 2025: Grant or award of APYX derivative securities (Form 4, code A).

Other insiders filing for Apyx Medical Corp (APYX)

Waldman Lawrence, Director
Roman Shawn David, Chief Operating Officer
Vizirgianakis Stavros G., Director
Goodwin Charles D. II, Chief Executive Officer
Baylor-Henry Minnie, Director
HILL MATTHEW C, Chief Financial Officer

How to read Form 4 transaction codes